San Francisco, 30 October 2024: The Report Biohacking Market Size, Share & Trends Analysis Report By Product, By Application (Synthetic Biology, Drug Testing), By End-use (Hospitals & Clinics, Pharma & Biotech Companies), By Region, And Segment Forecasts, 2024 - 2030

The global biohacking market size is anticipated to reach USD 67.86 billion by 2030, registering a CAGR of 18.6% from 2024 to 2030, according to a new report by Grand View Research, Inc. Various initiatives by market players and rising funds for biohacking are the major factors fueling the market growth. The adoption of biohacking practices is growing due to their potential applications in decreasing the risk of developing a disease, especially genetically associated diseases, helping an individual to achieve mental, physical, or emotional changes, such as weight loss or reducing depression symptoms; and optimize general functions of the body, such as blood pressure.

The global market has been significantly affected by the COVID-19 pandemic. Some of the major impacts of COVID-19 on the market include supply chain disruptions, a decline in sales, and low demand. However, biohackers in the industry are investing in some research activities for the development of COVID-19 vaccines as well as test kits. This neutralized the market growth in 2020. For the purchase of equipment and materials, biohackers require basic funding. Other than crowdfunding, most of the activities at these labs are self-funded through membership and workshop fees. Furthermore, private donations are also used for raising money.

Oura Health, manufacturer of the Oura ring, a sleep-improvement and sleep tracking platform, raised USD 20 million in Series B funding led by MSD Capital in December 2018. The global market is fairly competitive. Most of the market players have undertaken strategies, such as new product launches, acquisitions, and partnerships, to gain a competitive edge over each other. For instance, in September 2020, Apple Inc. partnered with the government of Singapore for launching a national health initiative using Apple Watch. With this, the country made an effort to leverage technology for delivering advanced health benefits to its citizens.

Request sample report of Biohacking Market@ https://www.grandviewresearch.com/industry-analysis/biohacking-market/request/rs1

Factors expected to drive the growth of the biohacking market are the availability of wearable health trackers, genetic testing kits, smart devices, and apps that allow people to track and analyze their biometric data, leading to a more personalized and data-focused biohacking approach. Another significant trend in the market that is anticipated to drive the growth of the biohacking industry is the increasing worries regarding lifestyle-related illnesses. Furthermore, many individuals seek methods to enhance their lifespan, prevent or deal with health issues, and optimize their mental and physical abilities.

Biohacking Market Report Highlights

• The wearables segment accounted for a share of 29.9% in 2023. Current developments in this market mainly focus on technological progress, such as adding additional health functions, incorporating Artificial Intelligence for personalized suggestions, and sending live data to healthcare professionals for prompt interventions and better patient results.
• The diagnosis and treatment segment held the largest revenue share of over 32.3% in 2023 due to the high usage of biohacking practices, such as nootropics and wearable technologies, for body enhancement purposes.
• The hospitals and clinics segment held the largest share of 40.3% in 2023. The segment growth is credited to the increase in chronic diseases and their treatment.
• North America biohacking market dominated the market in 2023 with a market share of 36.7%. This is due to the increasing prevalence of chronic illnesses, increase in the awareness of biohacking, and an aging population in the region.
• Asia Pacific Biohacking market is anticipated to witness significant growth in 2023 with a CAGR of 20.6% attributing to the rise in healthcare expenditure that has led to economic growth in the region.

Biohacking has accelerated the advancement and innovation of cutting-edge products. It combines the characteristics of technology and synthetic biology. Scientists and research individuals conduct laboratory experiments to discover new possibilities in biotechnology, genetic engineering, and molecular biology. Biohackers engage in various body experiments, including tracking heart rate or implanting microchips for managing stress. Biohackers are working on multiple products to investigate the human body.

Among the products available are microchips, innovative drugs, brain sensors, magnetic fingertips, RFID implants, bacterial and yeast strains, body sensors, and health trackers. At present, wearable analytical technological devices are widely available. The current generation holds a favorable attitude towards biohacking and the tools associated with it. Biohacking can be used to monitor heart rate, steps, blood sugar level, body movement, calorie burn, or other data.

Biohacking Market Report Scope

Recent Developments

• In October 2023, Muse classified themselves as an eligible product for health savings accounts (HSA) and flexible spending accounts (FSA), benefiting customers with health improvements and tax savings. In collaboration with Truemed, they have simplified the payment procedure for customers, guaranteeing a straightforward and effective checkout process with health savings accounts when purchasing the new meditation devices, the Muse 2 Headband or the Muse S Headband.
• In May 2023, Google revealed a merger deal worth USD 2.1 billion with Fitbit. This agreement enhanced Google's placement in the wearable technology market. The deal involved acquiring Fitbit's brand, technology, and software, which was incorporated into Google's hardware operations.